Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ACTRIMS 2024 | The interdisciplinary management of NMOSD to improve clinical outcomes

Megan Weigel, DNP, ARNP-c, MSCN, Baptist Neurology Inc, Jacksonville Beach, FL, discusses the interdisciplinary management of neuromyelitis optica spectrum disorder (NMOSD). As NMOSD has come more to the forefront due to the FDA approval of three therapies and the founding of several patient advocacy organizations, the knowledge surrounding the disease is spreading. Patients with NMOSD typically exhibit a greater degree of disability than those with multiple sclerosis (MS) and their symptoms are often more difficult to manage. This leads to greater reliance on interprofessional care, which should be highlighted to patients early on to avoid them feeling overwhelmed by the involvement of further members of the interdisciplinary team. Ms Weigel also highlights the importance of nurse practitioners and physicians assistants, who are well-educated and trained to treat the difficult symptoms of NMOSD prior to a referral. This interview took place during the annual ACTRIMS Forum 2024.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Megan Weigel reports the following disclosures: Speaker’s bureaus: Biogen, Horizon/Amgen, Sanofi/Genzyme, TG Therapeutics; Consultant: Biogen, Horizon/Amgen, Sanofi/Genzyme, TG Therapeutics, EMD Serono.